My 3 Favorite Stocks to Buy Right Now

Three dividend-growth stocks—Coca-Cola (KO), Enbridge (ENB), and Medtronic (MDT)—are presented as compelling investment opportunities for their consistent dividend increases and current valuations. Coca-Cola, a Dividend King with a ~2.9% yield, is highlighted for its industry leadership and reasonable valuation. Enbridge, yielding 5.5% with 30 years of increases, offers a stable fee-based midstream energy model and is strategically transitioning to natural gas and renewables. Medtronic, a medical device giant, is undergoing a significant corporate overhaul, including a diabetes unit spin-off and new product launches, positioning it for renewed growth and offering a ~3% yield with 48 consecutive increases, underscoring opportunities for dividend-focused investors despite elevated market levels.

Analysis

The analysis identifies Coca-Cola (KO), Enbridge (ENB), and Medtronic (MDT) as attractive dividend-growth opportunities for conservative investors. These selections are underpinned by their consistent dividend increase histories, with KO holding Dividend King status and MDT approaching it with 48 consecutive increases. The article suggests these opportunities exist even as the S&P 500 trades near all-time highs with a low 1.2% yield.

Coca-Cola is presented as reasonably priced, with its price-to-earnings and price-to-book ratios below five-year averages, offering a ~2.9% dividend yield. Enbridge, a North American midstream energy giant, boasts an attractive 5.5% yield and a stable fee-based business model minimally impacted by energy price volatility. Enbridge is also strategically transitioning its portfolio towards natural gas and renewables, utilizing profits from traditional energy sources.

Medtronic is undergoing a significant corporate overhaul, including exiting less desirable business lines and a planned spin-off of its diabetes unit, which is expected to be immediately accretive to earnings. The company is also launching new products, such as surgical robot technology, positioning it for stronger growth and profitability. This restructuring, coupled with a historically high ~3% dividend yield, suggests an inflection point for the medical device maker.

Key Decisions for Investors

• Investors should consider Coca-Cola for its industry leadership, Dividend King status, and current valuation, which appears fair to slightly cheap based on P/E and P/B metrics.
• Evaluate Enbridge for its attractive 5.5% dividend yield, stable fee-based midstream energy business, and strategic pivot towards natural gas and renewable energy sources.
• Monitor Medtronic's ongoing corporate restructuring, including the diabetes unit spin-off and new product introductions, as these initiatives are expected to drive renewed growth and profitability, supporting its historically high ~3% dividend yield.
• Recognize that opportunities for attractive dividend-growth stocks persist, even in a high-valuation market environment, by focusing on companies with strong fundamentals and strategic initiatives.